A detailed history of State Street Corp transactions in Repligen Corp stock. As of the latest transaction made, State Street Corp holds 1,623,683 shares of RGEN stock, worth $239 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,623,683
Previous 1,737,424 6.55%
Holding current value
$239 Million
Previous $219 Million 10.33%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $13.6 Million - $19 Million
-113,741 Reduced 6.55%
1,623,683 $242 Million
Q2 2024

Aug 14, 2024

SELL
$120.0 - $182.95 $2.49 Million - $3.8 Million
-20,788 Reduced 1.18%
1,737,424 $219 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $9.32 Million - $11.4 Million
54,594 Added 3.2%
1,758,212 $323 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $5.64 Million - $9.16 Million
49,396 Added 2.99%
1,703,618 $306 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $404,127 - $513,997
2,912 Added 0.18%
1,654,222 $263 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $2.03 Million - $2.64 Million
14,647 Added 0.89%
1,651,310 $234 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $5.66 Million - $7.26 Million
36,669 Added 2.29%
1,636,663 $276 Million
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $33.5 Million - $45.5 Million
206,414 Added 14.81%
1,599,994 $271 Million
Q3 2022

Nov 15, 2022

BUY
$160.42 - $256.21 $2.95 Million - $4.71 Million
18,369 Added 1.34%
1,393,580 $261 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $818,757 - $1.09 Million
-5,820 Reduced 0.42%
1,375,211 $223 Million
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $5.43 Million - $8.68 Million
33,660 Added 2.5%
1,381,031 $260 Million
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $8.61 Million - $10.6 Million
34,757 Added 2.65%
1,347,371 $357 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $318,254 - $529,759
1,634 Added 0.12%
1,312,614 $379 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $20.1 Million - $26.8 Million
121,266 Added 10.19%
1,310,980 $262 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $2.34 Million - $2.93 Million
12,958 Added 1.1%
1,189,714 $231 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $5.95 Million - $8.3 Million
40,160 Added 3.53%
1,176,756 $226 Million
Q3 2020

Nov 10, 2020

SELL
$122.51 - $158.27 $5.73 Million - $7.4 Million
-46,779 Reduced 3.95%
1,136,596 $168 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $38.2 Million - $56.9 Million
-405,273 Reduced 25.51%
1,183,375 $146 Million
Q1 2020

May 11, 2020

BUY
$84.96 - $109.14 $135 Million - $173 Million
1,588,648 New
1,588,648 $153 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.